PMID: 16634465Apr 26, 2006Paper

Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics

American Journal of Alzheimer's Disease and Other Dementias
Peter Aupperle

Abstract

The behavioral and psychological symptoms of dementia (BPSD), such as psychosis, agitation, or aggression have a considerable negative impact on the quality of life of both patients and their caregivers. Multiple studies have demonstrated that atypical antipsychotics are efficacious in the treatment of the aggressive and psychotic symptom clusters, and here we review their use in this indication. Because of the safety concerns associated with the use of atypical antipsychotics in this population, these drugs must be used judiciously. For patients with severe BPSD such as psychosis, agitation, or aggression, for whom there are few options, atypical antipsychotics, particularly risperidone and olanzapine, should be considered.

References

Jan 1, 1992·Alzheimer Disease and Associated Disorders·L TeriC Phelps
May 1, 1990·Journal of the American Geriatrics Society·L S SchneiderS A Lyness
Aug 1, 1990·The American Journal of Psychiatry·C SteeleM Folstein
Jan 27, 1999·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·D V JesteJ Lacro
Aug 11, 2000·The Journal of Clinical Psychiatry·M F WeinerD A Svetlik
Sep 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M Zaudig
Oct 26, 2000·Clinical Therapeutics·P N TariotI W Rak
Mar 10, 2001·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·N Herrmann
Dec 12, 2001·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·L S SchneiderJ A Lieberman
Dec 12, 2001·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·J Cohen-Mansfield
Jun 1, 2002·Alzheimer Disease and Associated Disorders·Douglas W Scharre, Shu-Ing Chang
Dec 7, 2002·Clinical Neuropharmacology·Diana PaleacuYoram Barak
Mar 6, 2003·Journal of Clinical Pharmacology·Qinying ZhaoJean-Loup Parier
Apr 3, 2003·International Psychogeriatrics·Serge GauthierUNKNOWN Donepezil MSAD Study Investigators Group
Jul 24, 2003·Drugs & Aging·Gordon WilcockUNKNOWN GAL-GBR-2 Study Group
Jan 21, 2004·CNS Drugs·Michael K RainerSigfried Kasper
Mar 3, 2004·The American Journal of Psychiatry·Jeffrey L CummingsWeiying Yuan
Apr 28, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Eric Wooltorton
Jan 12, 2005·The Journal of Clinical Psychiatry·Benoit H MulsantBruce G Pollock
Feb 3, 2005·JAMA : the Journal of the American Medical Association·Kaycee M SinkKristine Yaffe
Aug 4, 2005·The Annals of Pharmacotherapy·Rebecca B Sleeper
Oct 20, 2005·JAMA : the Journal of the American Medical Association·Lon S SchneiderPhilip Insel

❮ Previous
Next ❯

Citations

Mar 19, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Jana SchulzeFalk Hoffmann
Jul 20, 2014·Clinics in Geriatric Medicine·Lucy Y WangMarcella Pascualy
Sep 10, 2008·Expert Opinion on Pharmacotherapy·Karleen M McNealJacob Mintzer
Jul 2, 2011·Journal of the American Geriatrics Society·Leonor LaredoAntonio Portolés
Aug 12, 2009·International Journal of Geriatric Psychiatry·Prasad S NishtalaTimothy F Chen
Apr 3, 2012·Journal of the American Medical Directors Association·Orah R BurackJoann P Reinhardt
Jan 1, 2010·International Journal of Psychiatry in Medicine·Champa BalalleKunle Ashaye
Nov 6, 2009·PLoS Medicine·Martin J PrinceK S Shaji
Dec 31, 2015·Journal of the American Medical Directors Association·Massimiliano FedecostanteAntonio Cherubini
Aug 1, 2015·International Journal of Nursing Studies·Avis R Ing-RandolphAnn B Williams
Aug 18, 2016·European Archives of Psychiatry and Clinical Neuroscience·Alexander WolfFrank-Gerald Pajonk
Nov 4, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Gianluca TrifiròGiovanni Gambassi
Mar 29, 2012·The Kaohsiung Journal of Medical Sciences·Yi-Chun Yeh, Wen-Chen Ouyang
Apr 3, 2012·American Journal of Alzheimer's Disease and Other Dementias·Kuljeet Singh Anand, Rohit Verma
Mar 3, 2009·Biological & Pharmaceutical Bulletin·Naoki UchidaMichihiro Fujiwara
Apr 20, 2017·Psychopharmacology·Janitza L Montalvo-OrtizHongxin Dong
Aug 3, 2012·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Joseph H PuyatSteven G Morgan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here